SyncroMD

Executive Summary

SyncroMD is a clinical research site and medical center headquartered in Bucharest, Romania, dedicated to advancing medical knowledge through innovative clinical trials across multiple therapeutic areas. Founded in 2017, the company operates with a strong emphasis on patient safety, regulatory compliance, and community engagement. As a site-based organization, SyncroMD serves as a vital link between pharmaceutical sponsors and patient populations, enabling the execution of high-quality trials in a region with growing clinical research activity. The company is positioned to benefit from the increasing globalization of clinical trials and the rising demand for diverse patient populations. With a focus on operational excellence and adherence to international standards, SyncroMD aims to attract more sponsors and expand its portfolio of studies. While currently a private entity with limited public information, its established presence in Romania and commitment to medical progress suggest potential for steady growth. Key upcoming developments include securing new trial contracts, expanding into additional therapeutic areas, and forming strategic partnerships with pharmaceutical companies.

Upcoming Catalysts (preview)

• Q4 2026New clinical trial contracts from sponsors70% success
• Q1 2027Expansion into new therapeutic areas50% success
• Q3 2026Strategic partnership with a major pharmaceutical sponsor60% success